Clinical Trial Update: A Clinical Study to Assess Single and Repeat Doses of a New Medication (GSK933776) in Patients With Alzheimer's Disease [Phase 1]

View source ↗

Summary

A Phase 1 clinical study evaluating single and repeat dosing of GSK933776 in patients with Alzheimer's disease. The trial, sponsored by GlaxoSmithKline, has com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• GSK933776

Snippet

Sponsor: GlaxoSmithKline | Conditions: Alzheimer's Disease | Phase 1 | Status: COMPLETED